NCT05383508View on ClinicalTrials.gov

Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

June 29, 2022

Study Completion Date

August 25, 2022

Conditions
Nicotine VapingNicotineVaping
Interventions
OTHER

CA35

Nicotine concentration: 3.5 % e-liquid flavor: Tobacco

OTHER

CM35

Nicotine concentration: 3.5 % e-liquid flavor: Menthol

OTHER

Cig

Subjects' preferred brand of commercially available, regular or mentholated cigarettes

Trial Locations (1)

27265

High Point Clinical Trials Center (HPCTC), High Point

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY